138 related articles for article (PubMed ID: 9372316)
1. Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: results of a pilot study.
Wozel G; Blasum C; Winter C; Gerlach B
Inflamm Res; 1997 Oct; 46(10):420-2. PubMed ID: 9372316
[TBL] [Abstract][Full Text] [Related]
2. Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
Vage C; Saab N; Woster PM; Svensson CK
Toxicol Appl Pharmacol; 1994 Dec; 129(2):309-16. PubMed ID: 7992320
[TBL] [Abstract][Full Text] [Related]
3. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis.
Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gaginella TS
J Leukoc Biol; 1991 Mar; 49(3):283-8. PubMed ID: 1847716
[TBL] [Abstract][Full Text] [Related]
4. Dapsone inhibits the generation of 5-lipoxygenase products in human polymorphonuclear leukocytes.
Wozel G; Lehmann B
Skin Pharmacol; 1995; 8(4):196-202. PubMed ID: 7488396
[TBL] [Abstract][Full Text] [Related]
5. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin.
Wozel G; Chang A; Zultak M; Czarnetzki BM; Happle R; Barth J; van de Kerkhof PC
Arch Dermatol Res; 1991; 283(3):158-61. PubMed ID: 1651071
[TBL] [Abstract][Full Text] [Related]
6. Dapsone-induced photodermatitis in a patient with linear IgA dermatosis.
Stöckel S; Meurer M; Wozel G
Eur J Dermatol; 2001; 11(1):50-3. PubMed ID: 11174140
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate.
Dos Santos C; Davidson D
Pediatr Res; 1993 Mar; 33(3):242-6. PubMed ID: 8384710
[TBL] [Abstract][Full Text] [Related]
8. Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels.
Maloff BL; Fox D; Bruin E; Di Meo TM
Eur J Pharmacol; 1988 Dec; 158(1-2):85-9. PubMed ID: 2851461
[TBL] [Abstract][Full Text] [Related]
9. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
Reilly TP; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
[TBL] [Abstract][Full Text] [Related]
10. Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients.
Garg SK; Kumar B; Bakaya V; Lal R; Shukla VK; Kaur S
Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):552-4. PubMed ID: 3243659
[TBL] [Abstract][Full Text] [Related]
11. Oxygen free radicals are required for ischemia-induced leukotriene B4 synthesis and diapedesis.
Goldman G; Welbourn R; Klausner JM; Valeri CR; Shepro D; Hechtman HB
Surgery; 1992 Mar; 111(3):287-93. PubMed ID: 1311874
[TBL] [Abstract][Full Text] [Related]
12. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Irshaid Y; Adedoyin A; Lotze M; Branch RA
Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
[TBL] [Abstract][Full Text] [Related]
13. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
Grossman SJ; Jollow DJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of K-C1 cotransport in rat red cells by a hemolytic anemia-producing metabolite of dapsone.
Haas M; Harrison JH
Am J Physiol; 1989 Feb; 256(2 Pt 1):C265-72. PubMed ID: 2919657
[TBL] [Abstract][Full Text] [Related]
15. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.
Kankaanranta H; Moilanen E; Vapaatalo H
Inflammation; 1991 Apr; 15(2):137-43. PubMed ID: 1649132
[TBL] [Abstract][Full Text] [Related]
16. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
Chang A; van de Kerkhof PC
Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro.
McCain RW; Holden EP; Blackwell TR; Christman JW
Am J Respir Cell Mol Biol; 1994 Jun; 10(6):651-7. PubMed ID: 8003341
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic observations on dapsone in dermatitis herpetiformis.
Swain AF; Ahmad RA; Rogers HJ; Leonard JN; Fry L
Br J Dermatol; 1983 Jan; 108(1):91-8. PubMed ID: 6821646
[TBL] [Abstract][Full Text] [Related]
19. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
Ternowitz T; Fogh K; Kragballe K
Skin Pharmacol; 1988; 1(2):93-9. PubMed ID: 2856182
[TBL] [Abstract][Full Text] [Related]
20. Chemotaxis of polymorphonuclear leukocytes towards LTB4 in patients with psoriasis in vitro.
Sun RZ; Zhou DY; Zheng MR; Yue TL
Chin Med J (Engl); 1990 Jul; 103(7):595-8. PubMed ID: 2170083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
